Prevalence of microalbuminuria among patients with type 2 diabetes mellitus-A hospital-based study from North India

Diabetes Technology and Therapeutics

Volumn 12, Issue 2, 2010, Pages 161-166

  Kanakamani, J ^a,b   Ammini, A C ^a   Gupta, Nandita ^a   Dwivedi, S N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN;

ADULT; ALBUMINURIA; ARTICLE; ASIAN; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INDIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SMOKING; SOCIOECONOMICS; URINALYSIS; WAIST CIRCUMFERENCE;

ALBUMINURIA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INDIA; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; URINALYSIS;

EID: 76449107852     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0133     Document Type: Article

References (32)

1. International Diabetes Federation: Cost-Effective Approaches to Diabetes Care and Prevention. IDF Task Force on Diabetes Health Economics. Brussels: International Diabetes Federation, 2003.
2. Mohan V: Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007;125:217-230. (Pubitemid 46805444)
3. Burden AC, McNally PG, Feehally J, Walls J: Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabet Med 1992;9:641-645.
4. 2nd Annual Report CKD Registry of India Indian Society of Nephrology. http://www.ckdri.org/2nd-Annual-Report-CKD .pdf (accessed August 25, 2009).
5. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen ER, Feldt-Rasmussen B, Schimtz A, Viberti GC: Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985-1986;9:85-95.
6. Adler AI, Stevens RJ, Manley SE Bilous RW, Cull CA, Holman RR; UKPDS Group: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63: 225-232.
7. Esmatjes E, Castell C, Gonzalez T, Tresserras R, Lloveras G: Epidemiology of renal involvement in type II diabetics (NIDDM) in Catalonia. The Catalan Diabetic Nephropathy Study Group. Diabetes Res Clin Pract 1996;32:157-163.
8. Hamman RF, Franklin GA, Mayer EJ, Marshall JA, Baxter J, Kahn LB: Microvascular complications of NIDDM in Hispanics and non-Hispanic whites. Diabetes Care 1991;14: 655-664.
9. Young BA, Katon WJ, Von Korff M, Simon GE, Lin EH, Ciechanowski PS, Bush T, Oliver M, Ludman EJ, Boyko EJ: Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. J Am Soc Nephrol 2005;16:219-228.
10. Alzaid AA, Sobkib S, De Silva V: Prevalence of microalbuminuria in Saudi Arabians with non-insulin-dependent diabetes mellitus: a clinic-based study. Diabetes Res Clin Pract 1994;26:115-120.
11. Allawi J, Rao PV, Gilbert R, Scott G, Jarrett RJ, Keen H, Viberti GC, Mather HM: Microalbuminuria in non-insulindependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) 1988;296: 462-464.
12. Fischbacher CM, Bhopal R, Rutter MK, Unwin NC, Marshall SM, White M, Alberti KG: Microalbuminuria is more frequent in South Asian than in European origin populations: a comparative study in Newcastle, UK. Diabet Med 2003;20; 31-36.
13. Mather HM, Chaturvedi N, Kehely AM: Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus. Diabet Med 1998;15:672-677.
14. Metcalf PA, Baker JR, Scragg RK, Dryson E, Scott AJ, Wild CJ: Microalbuminuria in a middle-aged workforce. Diabetes Care 1993;16:1485-1493.
15. Chandieshaw PK, Vandenbroucke JP, Tjandra YI, Rosendaal FR, Rosman JB, Geerlings W, de Charro FT, van Es LA: Increased end-stage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands. Diabetologia 2002;45: 337-341.
16. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR; UKPDS Study Group: Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006;55:1832-1839.
17. Ahmedani MY, Hydrie MZ, Iqbal A, Gul A, Mirza WB, Basit A: Prevalence of microalbuminuria in type 2 diabetic patients in Karachi: Pakistan. A multi-centre study. J Pak Med Assoc 2005:55:382-386.
18. John L, Rao PS, Kanagasabapathy AS: Rate of progression of albuminuria in type II diabetes. Five-year prospective study from south India. Diabetes Care 1994;17:888-890.
19. Viswanathan VV, Snehalatha C, Ramachandran A, Viswanathan M: Proteinuria in NIDDM in south India: analysis of predictive factors. Diabetes Res Clin Pract 1995;28:41-46.
20. Varghese A, Deepa R, Rema M, Mohan V: Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Postgrad Med J 2001;77:399-402.
21. Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, Mohan V: Prevalence and risk factors of diabetic nephropathy in an urban South Indian population- the Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 2007;30:2019-2024.
22. World Health Organization: Diabetes Mellitus. Report of a WHO Study Group. Technical Report Series Number 727. Geneva: World Health Organization, 1985.
23. World Health Organization: Physical Status: The Use and Interpretation of Anthropometry. Geneva: World Health Organization, 1995.
24. Davidson MB, Smiley JF: Relationship between dipstick positive proteinuria and albumin:creatinine ratios. J Diabetes Complications 1999;13:52-55.
25. Leong SO, Lui KF, Ng WY, Thai AC: The use of semiquantitative urine test-strip (Micral Test) for microalbuminuria screening in patients with diabetes mellitus. Singapore Med J 1998;39:101-103.
26. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572.
27. World Health Organization: The Asia-Pacific Perspective. Redefining Obesity and Its Treatment. International Diabetes Institute, 2000. http://www.wpro.who.int/internet/ resources.ashx/NUT/Redefining+obesity.pdf (accessed August 25, 2009).
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-470.
29. Wu AYT, Kong NCT, de Leon FA, Pan CY, Tai TY, Yeung VTF, Yoo SJ, Rouillon A, Weir MR; MAPS Investigators: An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients; the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005;48:17-26.
30. Yajnik CS, Naik SS, Raut KN, Khade AD, Bhat DS, Nagarkar VD, Deshpande JA: Urinary albumin excretion rate (AER) in newly-diagnosed type 2 Indian diabetic patients is associated with central obesity and hyperglycaemia. Diabetes Res Clin Pract 1992;17:55-60.
31. Census of India: The census data summary, 2001. http:// www.censusindia.gov.in/ (accessed June 9, 2009).
32. American Diabetes Association: Diabetic nephropathy. Position statement. Diabetes Care 2002;25(Suppl 1):S85-S89.